Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.36 | 0.06 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.086 | 0.07 |